IGF-1 DES(1-3)
Also known as: Des(1-3) IGF-1, DES IGF
Truncated IGF-1 missing first 3 amino acids; 10x more potent than IGF-1 at the receptor due to reduced IGFBP binding. Promotes hyperplasia.
- Typical dose
- 20 mcg – 100 mcg
- Frequency
- once daily
- Route
- Subcutaneous
- Half-life
- 19 minutes
- Routes
- Subcutaneous, Intramuscular
- Status
- Research chemical
Benefits
- Muscle hyperplasia (new cells)
- 10x IGF-1 potency
- Localized muscle growth
- Recovery enhancement
Dosing
A common research range for IGF-1 DES(1-3) is 20 mcg to 100 mcg once daily. Inject locally into target muscle post-workout; very short half-life. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for IGF-1 DES(1-3) is 1 mg of peptide in 1 mL of bacteriostatic water, giving roughly 1 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
IGF-1 DES(1-3) has an approximate half-life of 19 minutes. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.
Storage
2-8°C; extremely fragile; use within 24h of reconstitution.
Reported side effects
- Hypoglycemia
- Joint pain
- Localized swelling
Contraindications
- Active cancer
- Diabetes (uncontrolled)
- Pregnancy
Commonly stacked with
Track IGF-1 DES(1-3) with Vial
Vial logs every IGF-1 DES(1-3) dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. IGF-1 DES(1-3) is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.